XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:        
Net income $ 320 $ 26 $ 345 $ 20
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 105 125 211 241
Deferred income taxes     9 (17)
Stock-based compensation expense 3 2 7 8
Impairment and (gain) loss on sale of businesses, net (239) 10 (263) 27
Gain from early extinguishment of debt (138) (26) (138) (26)
Other non-cash expenses, net     92 94
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:        
Patient accounts receivable     (26) 39
Supplies, prepaid expenses and other current assets     (13) (23)
Accounts payable, accrued liabilities and income taxes     46 (88)
Other     (62) (78)
Net cash provided by operating activities     208 197
Cash flows from investing activities:        
Acquisitions of facilities and other related businesses     0 (1)
Purchases of property and equipment     (176) (181)
Proceeds from disposition of hospitals and other ancillary operations     1,013 0
Proceeds from sale of property and equipment     5 4
Purchases of available-for-sale debt securities and equity securities     (72) (23)
Proceeds from sales of available-for-sale debt securities and equity securities     58 32
Purchases of investments in unconsolidated affiliates     0 (4)
Increase in other investments     (42) (34)
Net cash provided by (used in) investing activities     786 (207)
Cash flows from financing activities:        
Repurchase of restricted stock shares for payroll tax withholding requirements     (2) (2)
Deferred financing costs and other debt-related costs     (2) (9)
Proceeds from noncontrolling investors in joint ventures     1 1
Redemption of noncontrolling investments in joint ventures       (2)
Distributions to noncontrolling investors in joint ventures     (96) (84)
Other borrowings     15 18
Issuance of long-term debt     700 1,296
Proceeds from ABL Facility     2,189 1,906
Repayments of long-term indebtedness     (3,380) (3,113)
Net cash (used in) provided by financing activities     (575) 11
Net change in cash and cash equivalents     419 1
Cash and cash equivalents at beginning of period     37 38
Cash and cash equivalents at end of period 456 39 456 39
Supplemental disclosure of cash flow information:        
Interest payments (178) (211) (407) (360)
Income tax payments, net $ (181) $ (84) $ (101) $ (84)